Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.

Mur P, Aiza G, Sanz-Pamplona R, González S, Navarro M, Moreno V, Capellá G, Valle L.

Clin Cancer Res. 2015 Nov 1;21(21):4985. doi: 10.1158/1078-0432.CCR-15-1756. No abstract available.

2.

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.

Martínez-Aranda A, Hernández V, Guney E, Muixí L, Foj R, Baixeras N, Cuadras D, Moreno V, Urruticoechea A, Gil M, Oliva B, Moreno F, González-Suarez E, Vidal N, Andreu X, Seguí MA, Ballester R, Castella E, Sierra A.

Oncotarget. 2015 Dec 29;6(42):44254-73. doi: 10.18632/oncotarget.5471.

3.

Dietary flavonoids, lignans and colorectal cancer prognosis.

Zamora-Ros R, Guinó E, Alonso MH, Vidal C, Barenys M, Soriano A, Moreno V.

Sci Rep. 2015 Sep 15;5:14148. doi: 10.1038/srep14148.

4.

[Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].

Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V.

Gac Sanit. 2015 Nov-Dec;29(6):464-71. doi: 10.1016/j.gaceta.2015.07.002. Epub 2015 Sep 2. Review. Spanish.

5.

Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.

Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA.

Clin Epigenetics. 2015 Jul 24;7:74. doi: 10.1186/s13148-015-0110-4. eCollection 2015.

6.

Genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.

Nat Commun. 2015 Jul 7;6:7138. doi: 10.1038/ncomms8138. Erratum in: Nat Commun. 2015;6:8739. Kury, Sebastian; Giocannucci, Edward L. and Lemire, Mathiew [Corrected to Küry, Sébastien; Giovannucci, Edward L. and Lemire, Mathieu].

7.

Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.

Costas L, Sequera VG, Quesada P, Altzibar JM, Lope V, Pérez-Gómez B, Benavente Y, Martín V, Casabonne D, Robles C, Llorca J, Moreno-Iribas C, Fernandez-Tardón G, Moreno V, Caballero-Granado FJ, Salas D, Jiménez-Moleón JJ, Marcos-Gragera R, Chirlaque MD, Amiano P, Molina AJ, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, de Sanjosé S.

Menopause. 2015 Oct;22(10):1138-46. doi: 10.1097/GME.0000000000000487.

PMID:
26125537
8.

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J.

Endocr Relat Cancer. 2015 Aug;22(4):545-59. doi: 10.1530/ERC-15-0029. Epub 2015 Jun 22.

PMID:
26099684
9.

Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V.

Clin Cancer Res. 2015 Oct 15;21(20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159. Epub 2015 Jun 12.

10.

An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.

Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J.

Dig Liver Dis. 2015 Sep;47(9):797-804. doi: 10.1016/j.dld.2015.05.004. Epub 2015 May 15.

PMID:
26055489
11.

Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L.

Gastroenterology. 2015 Sep;149(3):563-6. doi: 10.1053/j.gastro.2015.05.056. Epub 2015 Jun 5.

12.

DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study.

Salas LA, Bustamante M, Gonzalez JR, Gracia-Lavedan E, Moreno V, Kogevinas M, Villanueva CM.

Epigenetics. 2015;10(7):650-61. doi: 10.1080/15592294.2015.1057672.

13.

Association of diabetes and diabetes treatment with incidence of breast cancer.

García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M.

Acta Diabetol. 2016 Feb;53(1):99-107. doi: 10.1007/s00592-015-0756-6. Epub 2015 Apr 29.

14.

Altered pathways and colorectal cancer prognosis.

Moreno V, Sanz-Pamplona R.

BMC Med. 2015 Apr 8;13:76. doi: 10.1186/s12916-015-0307-6.

15.

miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.

Bu P, Wang L, Chen KY, Rakhilin N, Sun J, Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, Huan Chen J, Zessin AS, Shealy J, Cummings B, Hsu D, Lipkin SM, Moreno V, Gümüş ZH, Shen X.

Nat Commun. 2015 Apr 15;6:6879. doi: 10.1038/ncomms7879.

16.

Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.

Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V.

Gastroenterol Res Pract. 2015;2015:672410. doi: 10.1155/2015/672410. Epub 2015 Feb 24.

17.

Walking, biking or sport: how Spanish women attending breast cancer screening meet physical activity recommendations?

Peiró-Pérez R, Salas D, Vallés G, Abad-Fernandez MS, Vidal C, Sanchez-Contador Escudero C, Ascunce-Elizaga N, Zubizarreta R, Pedraz C, Pérez-Gómez B, Navarrete-Muñoz EM, Vioque J, Pollán M; DDM-Spain.

Eur J Public Health. 2015 Oct;25(5):857-63. doi: 10.1093/eurpub/cku248. Epub 2015 Mar 12.

PMID:
25767095
18.

Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design.

Castaño-Vinyals G, Aragonés N, Pérez-Gómez B, Martín V, Llorca J, Moreno V, Altzibar JM, Ardanaz E, de Sanjosé S, Jiménez-Moleón JJ, Tardón A, Alguacil J, Peiró R, Marcos-Gragera R, Navarro C, Pollán M, Kogevinas M; MCC-Spain Study Group.

Gac Sanit. 2015 Jul-Aug;29(4):308-15. doi: 10.1016/j.gaceta.2014.12.003. Epub 2015 Jan 19. Erratum in: Gac Sanit. 2018 Sep - Oct;32(5):501.

19.

Intrinsic cancer subtypes--next steps into personalized medicine.

Santos C, Sanz-Pamplona R, Nadal E, Grasselli J, Pernas S, Dienstmann R, Moreno V, Tabernero J, Salazar R.

Cell Oncol (Dordr). 2015 Feb;38(1):3-16. doi: 10.1007/s13402-014-0203-7. Epub 2015 Jan 14. Review.

PMID:
25586691
20.

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R.

Oncologist. 2015 Feb;20(2):127-33. doi: 10.1634/theoncologist.2014-0325. Epub 2015 Jan 5.

Supplemental Content

Loading ...
Support Center